The impact of diabetes on depression treatment outcomes

General Hospital Psychiatry

Volumn 32, Issue 1, 2010, Pages 33-41

  Bryan, Charlene ^a   Songer, Thomas ^b   Brooks, Maria Mori ^b   Rush, A John ^c   Thase, Michael E ^a   Gaynes, Bradley ^d   Balasubramani, G K ^b   Trivedi, Madhukar H ^c   Fava, Maurizio ^e   Wisniewski, Stephen R ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Depression; Diabetes; Remission

Indexed keywords

CITALOPRAM;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PROGNOSIS; REMISSION; SUICIDAL IDEATION;

ADOLESCENT; ADULT; AGED; CONFIDENCE INTERVALS; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; REMISSION INDUCTION; YOUNG ADULT;

EID: 73549123255     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2009.07.009     Document Type: Article

References (44)

1. Oslin D.W., Datto C.J., Kallan M.J., Katz I.R., Edell W.S., and TenHave T. Association between medical comorbidity and treatment outcomes in late-life depression. J Am Geriatr Soc 50 5 (2002) 823-828
2. Patten S.B., Beck C.A., Kassam A., William J.V., Barbui C., and Metz L.M. Long-term medical conditions and major depression: strength of association for specific conditions in the general population. Can J Psychiatry 50 (2005) 195-202
3. Brown C., Schulberg H.C., Sacco D., Perel J.M., and Houck P.R. Effectiveness of treatments for major depression in private care practice: a post hoc analysis of outcomes for African American and White patients. J Affect Disord 53 2 (1998) 185-192
4. Varner R.V., Ruiz P., and Small D.R. Black and White patients' response to antidepressant treatment for major depression. Psychiatr Q 69 2 (1998) 117-125
5. Brown C., Schulberg H.C., and Progerson H.G. Factors associated with symptomatic improvement and recovery from major depression in primary care patients. Gen Hosp Psychiatry 22 4 (2000) 242-250
6. Patten S.B. Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry 44 (1999) 151-157
7. Iosifescu D.V., Nierenberg A.A., Alpert J.E., et al. The impact of medical comorbidity on acute treatment in major depressive disorder. Am J Psychiatry 160 (2003) 2122-2127
8. Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. The prevalence of comorbid depression in adults with diabetes - a meta-analysis. Diabetes Care 24 (2001) 1069-1078
9. Egede L.E., Zheng D., and Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25 3 (2002) 464-470
10. Simon G.E., Von Korff M., and Lin E.H. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol Med 35 2 (2005) 271-279
11. Lustman P.J., Griffith L.S., Clouse R.E., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59 3 (1997) 241-250
12. Lustman P., Griffith L.S., Freedland K.E., Kissel S.S., and Clouse R.E. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized controlled trial. Ann Intern Med 129 8 (1998) 613-621
13. Lustman P., Freedland K.E., Griffith L.S., and Clouse R.E. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23 5 (2000) 618-623
14. Katon W.J., Von Korff M., Lin E.H., et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 61 (2004) 1042-1049
15. Lustman P., Clouse R., Nix B.D., et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 63 5 (2006) 521-529
16. De Groot M., Anderson R., Freedland K.E., Clouse R.E., and Lustman P.S. Association of diabetes complications and depression in type 1 and type 2 diabetes: a meta-analysis. Diabetes 49 S1 (2000) A63-A64
17. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
18. Fava M., Rush A.J., Trivedi M.H., et al. Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am 26 2 (2003) 457-494
19. Rush A., Fava M., Wisniewski S., et al. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control Clin Trials 25 1 (2004) 119-142
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
21. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Psychol 6 (1967) 278-296
22. Rush A.J., Trivedi M.H., Ibrahim H.M., et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self-Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54 5 (2003) 573-583
23. Trivedi M.H., Rush A.J., Ibrahim H.M., et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 34 1 (2004) 73-82
24. Rush A.J., Giles D.E., Schlesser M.A., Fulton C., Weissenburger J.E., and Burns C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 18 (1986) 65-87
25. Rush A.J., Gullion C.M., Basco M.R., Jarrett R.B., and Trivedi M.H. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26 (1996) 477-486
26. Novick J.S., Stewart J.W., Wisniewski S.R., et al. Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D. J Clin Psychiatry 66 8 (2005) 1002-1011
27. Fava M., Alpert J.E., Carmin C.N., et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 34 7 (2004) 1299-1308
28. Khan A.Y., Carrithers J., Preskorn S.H., et al. Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry 18 2 (2006) 91-98
29. Zimmerman M., and Mattia J. The reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders (The Psychiatric Diagnostic Screening Questionnaire). J Clin Psychiatry 60 (1999) 677-683
30. Zimmerman M., and Mattia J. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 58 8 (2001) 787-794
31. Linn B.S., Linn M.W., and Gurrel L. Cumulative Illness Rating Scale. J Am Geriatr Soc 16 (1968) 622-626
32. Miller M.D., and Towers A. A manual of guidelines for scoring the Cumulative Rating Scale for Geriatrics (CIRS-G) (1991), University of Pittsburgh, Pittsburgh (PA)
33. Miller M., Paradis C., and Houck P. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41 (1992) 237-248
34. Endicott J., Nee J., Harrison W., and Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q): a new measure. Psychopharmacol Bull 29 (1993) 321-326
35. Ware Jr. J.E., Kosinski M., and Keller S.D. A 12 item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 3 (1996) 220-233
36. Mundt J.C., Kobak K.A., Greist J.H., and Marks I.M. Work and Social Adjustment Scale: a simple measure of impairment and functioning. Br J Psychiatry 180 (2002) 461-464
37. Reilly M., Tanner A., and Meltzer E. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest 11 5 (1996) 278-288
38. Bryan C., Songer T., Brooks M., et al. A comparison of baseline sociodemographic and clinical characteristics between major depressive disorder patients with and without diabetes: a STAR*D report. J Affect Disord 108 1-2 (2008) 113-120
39. Fleiss J. Statistical methods for rates and proportions (1981), John Wiley and Sons, New York 212-236
40. Stahl S. Placebo-controlled comparison of selective serotonin uptake inhibitors citalopram and sertraline. Biol Psychiatry 48 9 (2000) 894-901
41. Trivedi M.H., Rush A.J., Wisniewski S.R., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163 1 (2006) 28-40
42. Wisniewski S.R., Rush A.J., Balasubramani G., Trivedi M.H., and Nierenberg A.A. Self-rated global measure of the frequency, intensity and burden of side effects. J Psychiatr Pract 12 2 (2006) 71-79
43. Lustman P., Williams M., Sayuk G., Nix B., and Clouse R. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 30 3 (2007) 459-466
44. Trivedi M., Rush A., Gaynes B., et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology 32 12 (2007) 2479-2489